oxlumo.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * # CSS, JS, Images Allow: /core/*.css$ Allow: /core/*.css? Allow: /core/*.js$ Allow: /core/*.js? Allow: /core/*.gif Allow: /core/*.jpg Allow: /core/*.jpeg Allow: /core/*.png Allow: /core/*.svg Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? Allow: /profiles/*.gif Allow: /profiles/*.jpg Allow: /profiles/*.jpeg Allow: /profiles/*.png Allow: /profiles/*.svg # Directories Disallow: /core/ Disallow: /profiles/ # Files
Meta Tags
Title OXLUMO® (lumasiran) | Official Patient
Description The first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 OXLUMO® (lumasiran) is the first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) by lowering oxalate in urine. See Important Safety Information on risk of injection site
Keywords N/A
Server Information
WebSite oxlumo faviconoxlumo.com
Host IP 23.185.0.4
Location -
Related Websites
Site Rank
More to Explore
oxlumo.com Valuation
US$5,992,156
Last updated: 2023-05-17 04:00:23

oxlumo.com has Semrush global rank of 1,766,360. oxlumo.com has an estimated worth of US$ 5,992,156, based on its estimated Ads revenue. oxlumo.com receives approximately 691,403 unique visitors each day. Its web server is located in -, with IP address 23.185.0.4. According to SiteAdvisor, oxlumo.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$5,992,156
Daily Ads Revenue US$5,532
Monthly Ads Revenue US$165,937
Yearly Ads Revenue US$1,991,240
Daily Unique Visitors 46,094
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
oxlumo.com. A 86400 IP: 23.185.0.4
oxlumo.com. AAAA 86400 IPV6: 2620:12a:8000::4
oxlumo.com. AAAA 86400 IPV6: 2620:12a:8001::4
oxlumo.com. NS 86400 NS Record: nsgbr.comlaude.co.uk.
oxlumo.com. NS 86400 NS Record: nssui.comlaude.ch.
oxlumo.com. NS 86400 NS Record: nsusa.comlaude.net.
HtmlToTextCheckTime:2023-05-17 04:00:23
Utility Navigation (mobile) For US Residents Only Questions? Call 1‑833‑256‑2748 Important Safety Information Full Prescribing Information Healthcare Professional Site Patient Site Utility Navigation (desktop) For US Residents Only Questions? Call 1‑833‑256‑2748 Important Safety Information Full Prescribing Information Healthcare Professional Site Patient Site Main navigation What Is PH1? Learn About OXLUMO® Starting OXLUMO® Patient Support Get Updates Connect With an Educator For Alnylam Assist™ Call: 1-833-256-2748 Monday-Friday, 8 AM -6 PM HEALTHCARE PROFESSIONAL SITE CONNECT WITH AN ALNYLAM EDUCATOR Image The first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1). OXLUMO® (lumasiran) is a prescription medicine for the treatment of PH1 to lower oxalate in urine and blood in children and adults. Tell Me About OXLUMO® Learn More About PH1 Natalie Person with PH1* *Alnylam is proud to feature real patients in our advertising. Patients may or
HTTP Headers
HTTP/1.1 301 Moved Permanently
Retry-After: 0
Content-Length: 0
Server: Pantheon
Location: https://www.oxlumo.com/
X-Pantheon-Redirect: primary-domain-policy-doc
Date: Fri, 04 Mar 2022 09:23:05 GMT
Connection: close
X-Served-By: cache-bma1683-BMA
X-Cache: HIT
X-Cache-Hits: 0
X-Timer: S1646385786.702713,VS0,VE1
Age: 0
Accept-Ranges: bytes
Via: 1.1 varnish

HTTP/2 200 
cache-control: max-age=600, public
content-language: en
content-type: text/html; charset=UTF-8
etag: W/"1646035102"
expires: Sun, 19 Nov 1978 05:00:00 GMT
last-modified: Mon, 28 Feb 2022 07:58:22 GMT
link: ; rel="shortlink", ; rel="canonical"
link: ; rel="revision"
server: nginx
strict-transport-security: max-age=300
traceparent: 00-50a544db12b740fcbb03f7c15f7d1414-d53d9a4b95f9f538-00
x-cloud-trace-context: 50a544db12b740fcbb03f7c15f7d1414/15365607153087411512;o=0
x-content-type-options: nosniff
x-drupal-cache: HIT
x-drupal-dynamic-cache: HIT
x-frame-options: SAMEORIGIN
x-generator: Drupal 8 (https://www.drupal.org)
x-pantheon-styx-hostname: styx-fe4-a-c8f79d547-q9h4q
x-styx-req-id: b2d74148-9b9c-11ec-aac2-b6d4b691b347
x-ua-compatible: IE=edge
date: Fri, 04 Mar 2022 09:23:06 GMT
x-served-by: cache-mdw17341-MDW, cache-bma1641-BMA
x-cache: MISS, MISS
x-cache-hits: 0, 0
x-timer: S1646385786.870868,VS0,VE151
vary: Accept-Encoding, Cookie, Cookie, Cookie
age: 0
accept-ranges: bytes
via: 1.1 varnish, 1.1 varnish
content-length: 35978
oxlumo.com Whois Information
Domain Name: OXLUMO.COM
Registry Domain ID: 2370470283_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.comlaude.com
Registrar URL: http://www.comlaude.com
Updated Date: 2022-02-16T23:01:38Z
Creation Date: 2019-03-18T11:18:08Z
Registry Expiry Date: 2023-03-18T11:18:08Z
Registrar: Nom-iq Ltd. dba COM LAUDE
Registrar IANA ID: 470
Registrar Abuse Contact Email: abuse@comlaude.com
Registrar Abuse Contact Phone: +442074218250
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited
Name Server: NSGBR.COMLAUDE.CO.UK
Name Server: NSSUI.COMLAUDE.CH
Name Server: NSUSA.COMLAUDE.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-04T10:31:32Z <<<